Enhanced Antitumor Activity by the Combination of Dasatinib and Selinexor in Chronic Myeloid Leukemia.
Spampinato M, Zuppelli T, Dulcamare I, Longhitano L, Sambataro D, Santisi A, Alanazi AM, Barbagallo IA, Vicario N, Parenti R, Romano A, Musumeci G, Li Volti G, Palumbo GA, Di Raimondo F, Nicolosi A, Giallongo S, Del Fabro V.
Spampinato M, et al. Among authors: romano a.
Pharmaceuticals (Basel). 2024 Jul 5;17(7):894. doi: 10.3390/ph17070894.
Pharmaceuticals (Basel). 2024.
PMID: 39065744
Free PMC article.